Universe Pharmaceuticals (UPC) Competitors $4.71 +0.22 (+4.90%) As of 10/3/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock UPC vs. APM, AEON, BFRI, MTNB, EPIX, ADXN, ALBT, IMCC, KPRX, and HCWBShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Aptorum Group (APM), AEON Biopharma (AEON), Biofrontera (BFRI), Matinas Biopharma (MTNB), ESSA Pharma (EPIX), Addex Therapeutics (ADXN), Avalon GloboCare (ALBT), IM Cannabis (IMCC), Kiora Pharmaceuticals (KPRX), and HCW Biologics (HCWB). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Its Competitors Aptorum Group AEON Biopharma Biofrontera Matinas Biopharma ESSA Pharma Addex Therapeutics Avalon GloboCare IM Cannabis Kiora Pharmaceuticals HCW Biologics Aptorum Group (NASDAQ:APM) and Universe Pharmaceuticals (NASDAQ:UPC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Do analysts recommend APM or UPC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptorum Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Universe Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is APM or UPC more profitable? Company Net Margins Return on Equity Return on Assets Aptorum GroupN/A N/A N/A Universe Pharmaceuticals N/A N/A N/A Do insiders & institutionals have more ownership in APM or UPC? 3.8% of Aptorum Group shares are owned by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are owned by institutional investors. 64.0% of Aptorum Group shares are owned by insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, APM or UPC? Aptorum Group has a beta of 0.27, meaning that its stock price is 73% less volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500. Which has better earnings and valuation, APM or UPC? Aptorum Group has higher earnings, but lower revenue than Universe Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptorum Group$430K27.99-$4.27MN/AN/AUniverse Pharmaceuticals$23.02M0.11-$8.73MN/AN/A Does the media refer more to APM or UPC? In the previous week, Aptorum Group had 1 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 2 mentions for Aptorum Group and 1 mentions for Universe Pharmaceuticals. Aptorum Group's average media sentiment score of 0.23 beat Universe Pharmaceuticals' score of -1.00 indicating that Aptorum Group is being referred to more favorably in the media. Company Overall Sentiment Aptorum Group Neutral Universe Pharmaceuticals Negative SummaryAptorum Group beats Universe Pharmaceuticals on 6 of the 8 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.65M$2.63B$6.14B$10.58BDividend YieldN/A56.38%5.67%4.69%P/E RatioN/A24.2278.0526.70Price / Sales0.11726.66605.13131.81Price / CashN/A172.1237.9061.31Price / Book0.005.3412.556.55Net Income-$8.73M$32.92M$3.31B$277.50M7 Day Performance6.08%3.90%4.28%2.41%1 Month Performance26.27%10.60%7.85%9.30%1 Year PerformanceN/A-3.95%71.37%31.22% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse Pharmaceuticals0.3867 of 5 stars$4.71+4.9%N/AN/A$2.65M$23.02M0.00220Short Interest ↑APMAptorum Group0.696 of 5 stars$1.85+3.4%N/A+35.8%$9.89MN/A0.0030News CoveragePositive NewsShort Interest ↓Gap UpAEONAEON Biopharma1.0019 of 5 stars$0.84+8.1%$360.00+42,655.3%-99.0%$9.80MN/A4.685BFRIBiofrontera2.2766 of 5 stars$0.960.0%$2.75+186.5%-7.8%$9.73M$37.32M-0.4270Short Interest ↓MTNBMatinas Biopharma0.9999 of 5 stars$1.90+1.1%N/AN/A$9.67MN/A-0.3930News CoverageShort Interest ↓EPIXESSA Pharma3.8574 of 5 stars$0.20+0.4%$2.00+895.0%-96.6%$9.51MN/A-0.3650Dividend AnnouncementShort Interest ↓Gap UpADXNAddex Therapeutics0.4648 of 5 stars$8.87-1.9%$30.00+238.2%-2.1%$9.47M$170.62K-26.0930News CoverageEarnings ReportShort Interest ↑Gap UpALBTAvalon GloboCare1.6707 of 5 stars$2.46+2.5%N/A-25.3%$9.43M$1.33M-0.125News CoveragePositive NewsShort Interest ↓Gap DownIMCCIM CannabisN/A$1.77-0.6%N/A-11.2%$9.29M$39.44M-3.28340Gap UpKPRXKiora Pharmaceuticals3.4218 of 5 stars$2.61+1.6%$10.00+283.1%-21.2%$8.96M$16.02M-0.9010Positive NewsShort Interest ↓HCWBHCW Biologics1.8043 of 5 stars$4.09+0.2%$35.00+755.7%-77.0%$8.80M$2.57M-0.2940Positive News Related Companies and Tools Related Companies Aptorum Group Alternatives AEON Biopharma Alternatives Biofrontera Alternatives Matinas Biopharma Alternatives ESSA Pharma Alternatives Addex Therapeutics Alternatives Avalon GloboCare Alternatives IM Cannabis Alternatives Kiora Pharmaceuticals Alternatives HCW Biologics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPC) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPC Stock Alerts